| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7660c356e340012e7f21d12e56a91da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5572791fcbb838d309dd415c98acca73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50180f1e2e3f71c6f15383b7ff5a4189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa5cf2c2dc3f1758f5e9c7e3d69986d |
| publicationDate |
2020-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3630093-A1 |
| titleOfInvention |
TREATMENT OF DISEASES ASSOCIATED WITH A DYSREGULATION OF THE mTOR PATHWAY |
| abstract |
The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, for use in the prevention or treatment of a disease associated with a dysregulation of the mTOR pathway in an individual. |
| priorityDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |